Atlas Trials

Uterine Corpus Leiomyosarcoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Uterine Corpus Leiomyosarcoma

RecordFirmDate
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma (NCT03880019)National Cancer Institute (NCI)2019-08-19
Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma (NCT02428192)National Cancer Institute (NCI)2015-05-19
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery (NCT01958580)Albert Einstein College of Medicine2013-09-17
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus (NCT01637961)National Cancer Institute (NCI)2012-08-01
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery (NCT01533207)Gynecologic Oncology Group2012-06-04
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy (NCT01220609)National Cancer Institute (NCI)2010-11-01
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma (NCT01012297)National Cancer Institute (NCI)2009-11-01
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus (NCT00025220)National Cancer Institute (NCI)2001-09-01
Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442)Gynecologic Oncology Group1992-06-01

Track Uterine Corpus Leiomyosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.